735 findings · Metabolic adaptation · published 2017+
- Metabolic adaptationStrong
High fructose diets have lipogenic effects.
Consider the implications of high fructose consumption on lipogenesis in dietary recommendations.
Supports 2019 - Metabolic adaptationStrong
Chronic low-grade metabolic acidosis can have detrimental effects on systemic health, physical performance, and inflammation.
Athletes should be aware that chronic low-grade metabolic acidosis can negatively impact their health and performance.
Supports 2024 - Metabolic adaptationStrong
BMI and insulin use are jointly associated with one-year follow-up type 2 diabetes-related healthcare expenditures (T2D-HE), ranging from $5842 in overweight patients with no insulin to $17,700 in OCIII insulin users.
Healthcare providers can use BMI and insulin use to identify patients at higher risk for increased healthcare costs.
Supports 2019 - Metabolic adaptationStrong
Insulin users incur at least double the one-year T2D-HE compared to non-users within each BMI category.
Insulin therapy significantly increases healthcare costs for patients with type 2 diabetes.
Supports 2019 - Metabolic adaptationStrong
Metabolic health, rather than obesity, is a key predictor of adverse events in chronic coronary syndrome (CCS) prevention.
Practitioners should prioritize assessing metabolic health over BMI in cardiovascular risk evaluations.
Supports 2025New - Metabolic adaptationStrong
Approximately 80% of subjects had cholesterol levels outside recommended values after 6 years.
Monitoring cholesterol levels is important for older adults, even after exercise interventions.
Qualifies 2018 - Metabolic adaptationStrong
LCD may provide better glycemic control and is favorable for weight control and atherosclerosis prevention.
Adopting a low-carb diet could be beneficial for managing diabetes and preventing related health issues.
Supports 2021 - Metabolic adaptationStrong
MetFlex to fat displayed satisfactory test-retest reliability (intraclass correlation coefficient > 0.70) for several outcomes.
This method can reliably assess metabolic flexibility to high-fat meals in healthy individuals.
Supports 2025New - Metabolic adaptationStrong
Overnight changes in substrate oxidation following a high-fat dinner meal represent a unique aspect of MetFlex.
Practitioners should consider overnight metabolic responses when assessing dietary impacts.
Supports 2025New - Metabolic adaptationStrong
Postprandial plasma lipids and lipoproteins were examined after a 2-week low-carbohydrate diet compared to a 2-week low-fat diet.
This study provides insights into how different dietary approaches may affect lipid and lipoprotein levels post-meal.
Supports 2025New - Metabolic adaptationStrong
Die Gewichtsentwicklung in den ersten Wochen bis Monaten nach Initialisierung einer Therapie ist der stärkste Prädiktor für Gewichtszunahme assoziiert mit AP und AD.
Monitoring weight in the early stages of treatment can help predict long-term weight gain.
Supports 2024 - Metabolic adaptationStrong
The effectiveness of ESG is influenced by the patient's body mass index (BMI), being more effective in those with lower BMIs.
Practitioners should assess BMI when recommending ESG to optimize treatment outcomes.
Qualifies 2023 - Metabolic adaptationStrong
Sleeve gastrectomy can result in weight loss up to 23% at 1 year and is associated with a lower risk of malabsorption compared to Roux-en-Y gastric bypass.
Surgeons and healthcare providers should consider sleeve gastrectomy as a viable option for weight loss in transplant candidates.
Supports 2026New - Metabolic adaptationStrong
Die Gewichtsentwicklung in den ersten Wochen bis Monaten nach Initialisierung einer Therapie ist der stärkste Prädiktor für Gewichtszunahme assoziiert mit AP und AD.
Monitoring weight in the early stages of treatment can help predict long-term outcomes.
Supports 2025New - Metabolic adaptationStrong
The Open Formulary group had a modest weight reduction of −2.5 kg ± 4.4 kg.
Practitioners may note that an open formulary can also contribute to modest weight loss in patients.
Supports 2024 - Metabolic adaptationStrong
Obesity predicts cardiovascular disease mortality.
Practitioners should consider obesity as a significant risk factor for cardiovascular disease mortality.
Supports 2022 - Metabolic adaptationStrong
Higher BMIs are associated with the development of chronic kidney disease.
Weight management may be crucial for preventing chronic kidney disease.
Supports 2022 - Metabolic adaptationStrong
The removal of amino acids during hemodialysis contributes substantially to protein malnutrition in patients.
Practitioners should ensure adequate protein intake for patients undergoing hemodialysis.
Supports 2023 - Metabolic adaptationStrong
Participants with high baseline HbA1c experienced the greatest improvements in physical health (3.84 points) and mental health (3.3 points) scores.
High-risk individuals may see substantial improvements in both physical and mental health through digital health coaching.
Supports 2020 - Metabolic adaptationStrong
Higher total fat intake was associated with lower total mortality (HR 0.77).
Increasing total fat intake may contribute to improved longevity.
Supports 2018 - Metabolic adaptationStrong
Lower HbA1c is associated with 0.17 to 0.22 standard deviation better cognitive function across all domains.
Improving diabetes control to achieve lower HbA1c levels may enhance cognitive function in individuals with type 2 diabetes.
Supports 2025New - Metabolic adaptationStrong
There were no significant differences in changes in waist circumference, BMI, body fat, or metabolic risk factors between the two groups.
Practitioners may consider that time-restricted eating does not provide additional metabolic benefits compared to daily calorie restriction.
Refutes 2022 - Metabolic adaptationStrong
Each 5-unit increment in BMI was associated with a 20% increased risk of early-onset CRC (RR 1.20).
Weight management strategies may be important for reducing early-onset CRC risk.
Supports 2018 - Metabolic adaptationStrong
The association between glycemic load and cardiovascular events was similar to that of glycemic index among participants with cardiovascular disease at baseline, but not significant among those without preexisting cardiovascular disease.
Glycemic load may be a relevant factor for cardiovascular risk in individuals with existing conditions, but less so for those without.
Qualifies 2021